Intraperitoneal Meropenem for Polymicrobial Peritoneal Dialysis-Related Peritonitis

Concentrations of meropenem (mg/L) in plasma (circles) and peritoneal fluid (squares) during continuous intraperitoneal (i.p.) treatment with meropenem 125 mg/L. Plasma concentrations were measured at 1, 2, 4, 24, 144, 312, and 480 hours after administration of the first dose of IP meropenem. Concentrations in peritoneal fluid were measured at 0, 1, 2, and 4 hours after administration of the first dose